# Teva to expand Maipú plant capacity by 30% by 2026

Laboratorio Chile | Teva plans to increase production at its Maipú plant in Chile from 2.3 billion to 3 billion doses annually by 2026, a 30% increase, and further to 3.6 billion doses by 2028, requiring capacity and technology expansion.

- Type: Expansion
- Announced: 2023-03-24
- Where: Maipú, Chile, Chile
- Starts operating: 2026
- Status: announced
- Capacity: 3 billion doses per year by 2026, 3.6 billion by 2028
- Products: pharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Teva Pharmaceuticals](https://endata.com/companies/69307.md)
- [Laboratorio Chile](https://endata.com/companies/69308.md)

## Sources

- [df.cl](https://www.df.cl/empresas/salud/laboratorio-chile-teva-ampliara-su-capacidad-de-produccion-en-30-a), 2023-03-24: "Es una expansión muy significativa en el mediano plazo que va a proyectar los procesos que esta planta ha experimentado desde hace varios años."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.